Inventor · disambiguated record
John Michael Gansner
Also filed as: GANSNER JOHN M · GANSNER JOHN MICHAEL
1 granted patent·4 pending applications·1 citations·filing 2021–2024
17Inventor score
Files withALNYLAM PHARMACEUTICALS INC5
Top patents by PatentIndex Score
5 records- 0183US11866710B2Transmembrane protease, serine 6 (TMPRSS6) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2023·Granted Jan 9, 2024·1 cites·46 claims
- 0267US2024182905A1TRANSMEMBRANE PROTEASE, SERINE 6 (TMPRSS6) iRNA COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0361US2024344070A1Methods and compositions for treating subjects having or at risk of developing a non-primary hyperoxaluria disease or disorderALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0455US2025283071A1Modified double stranded oligonucleotidesALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0554US2023407312A1Methods and compositions for inhibition of hao1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expressionALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Michael Gansner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →